Kevin Chih-Yuan Ho
Director of Business and Clinical Development at Steminent Biotherapeutics- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
English -
-
Chinese (Traditional) -
Topline Score
Bio
Experience
-
Steminent Biotherapeutics
-
Taiwan
-
Biotechnology Research
-
1 - 100 Employee
-
Director of Business and Clinical Development
-
Mar 2020 - Present
Steminent Biotherapeutics Inc. is a global clinical-stage biopharmaceutical company devotes to stem cell therapies for unmet medical needs at its phase II stage. With the established proprietary technology platform and manufacturing capacity, Steminent is conducting two phase II clinical trials in USA and Taiwan and, with its partner, conducting one phase II clinical trial in Japan.
-
-
Manager of Business Development / Special Assistant to CEO
-
Mar 2014 - Mar 2020
-
-
Manager of Business Development / Special Assistant to President
-
Dec 2012 - Mar 2014
-
-
Manager of Medical Department
-
Apr 2012 - Dec 2012
-
-
-
National Taiwan University Alumni UK Association
-
London, United Kingdom
-
President
-
Dec 2011 - Apr 2012
The association works closely with the Taipei Representative Office in the UK to provide essential help and information to the alumni in the UK. The association works closely with the Taipei Representative Office in the UK to provide essential help and information to the alumni in the UK.
-
-
-
SINOPAC SECURITIES (EUROPE) LIMITED
-
United Kingdom
-
Financial Services
-
1 - 100 Employee
-
Internship Trainee
-
Nov 2011 - Apr 2012
SinoPac Securities is one of the leading securities firms in Taiwan which was ranked as “Best Underwriter” in 2004 and 2005 and as No.2 in Brokerage in Taiwan. SinoPac London office provides investment strategies and company research reports of Taiwan and Asia stock market to its Foreign Institutional Investors (FINIs). SinoPac Securities is one of the leading securities firms in Taiwan which was ranked as “Best Underwriter” in 2004 and 2005 and as No.2 in Brokerage in Taiwan. SinoPac London office provides investment strategies and company research reports of Taiwan and Asia stock market to its Foreign Institutional Investors (FINIs).
-
-
-
SHEN JIN Engineering CO., LTD
-
London, United Kingdom
-
Project Consultant
-
May 2011 - Apr 2012
The company devotes in construction industry and international trading of used cranes between Europe and Taiwan. The company devotes in construction industry and international trading of used cranes between Europe and Taiwan.
-
-
-
UCL
-
United Kingdom
-
Research Services
-
700 & Above Employee
-
Lead Technician
-
Apr 2009 - Feb 2011
-
-
-
Taipei Veterans General Hospital
-
Taiwan
-
Hospitals and Health Care
-
700 & Above Employee
-
Research Assistant
-
Feb 2004 - Nov 2005
-
-
Education
-
University College London, U. of London
PhD, Biomedical Engineering -
National Taiwan University
Bsc, Agricultural Chemistry